{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:58:42Z","timestamp":1777618722046,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12020-014-0316-9","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T18:03:00Z","timestamp":1402423380000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pathophysiological functions of adrenomedullin and natriuretic peptides in patients with primary aldosteronism"],"prefix":"10.1007","volume":"48","author":[{"given":"Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang-hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-geng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"issue":"3","key":"316_CR1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2012.08.022","volume":"425","author":"K Kitamura","year":"2012","unstructured":"K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, H. Matsuo, T. Eto, Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993. Biochem. Biophys. Res. Commun. 425(3), 548\u2013555 (2012). doi: 10.1016\/j.bbrc.2012.08.022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"316_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/187221412799015263","volume":"6","author":"BM Cheung","year":"2012","unstructured":"B.M. Cheung, F. Tang, Adrenomedullin: exciting new horizons. Recent Pat. Endocr. Metab. Immune Drug Discov. 6(1), 4\u201317 (2012)","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"issue":"9048","key":"316_CR3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(05)62827-9","volume":"349","author":"R Iorio Di","year":"1997","unstructured":"R. Di Iorio, E. Marinoni, D. Scavo, C. Letizia, E.V. Cosmi, Adrenomedullin in pregnancy. Lancet 349(9048), 328 (1997)","journal-title":"Lancet"},{"issue":"1","key":"316_CR4","first-page":"5","volume":"56","author":"J Beltowski","year":"2004","unstructured":"J. Beltowski, A. Jamroz, Adrenomedullin: what do we know 10\u00a0years since its discovery? Pol. J. Pharmacol. 56(1), 5\u201327 (2004)","journal-title":"Pol. J. Pharmacol."},{"issue":"4","key":"316_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.peptides.2007.12.006","volume":"29","author":"H Nishida","year":"2008","unstructured":"H. Nishida, T. Horio, Y. Suzuki, Y. Iwashima, K. Kamide, K. Kangawa, Y. Kawano, Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides 29(4), 599\u2013605 (2008). doi: 10.1016\/j.peptides.2007.12.006","journal-title":"Peptides"},{"issue":"1","key":"316_CR6","first-page":"10","volume":"11","author":"C Federico","year":"2010","unstructured":"C. Federico, Natriuretic peptide system and cardiovascular disease. Heart Views 11(1), 10\u201315 (2010)","journal-title":"Heart Views"},{"issue":"1\u20133","key":"316_CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jad.2010.09.002","volume":"129","author":"AGM Wis\u00e9n","year":"2011","unstructured":"A.G.M. Wis\u00e9n, K. Ekberg, B. Wohlfart, R. Ekman, A. Westrin, Plasma ANP and BNP during exercise in patients with major depressive disorder and in healthy controls. J. Affect. Disord. 129(1\u20133), 371\u2013375 (2011). doi: 10.1016\/j.jad.2010.09.002","journal-title":"J. Affect. Disord."},{"issue":"2","key":"316_CR8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jss.2013.03.036","volume":"184","author":"E TheodorakiArgyra","year":"2013","unstructured":"E. TheodorakiArgyra, K. Theodoraki, P. Rellia, A. Marinis, D. Voros, G. Polymeneas, Atrial and brain natriuretic peptide changes in an experimental model of intra-abdominal hypertension. J. Surg. Res. 184(2), 937\u2013943 (2013). doi: 10.1016\/j.jss.2013.03.036","journal-title":"J. Surg. Res."},{"issue":"3","key":"316_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjhyper.2004.09.016","volume":"18","author":"J Kato","year":"2005","unstructured":"J. Kato, T. Etoh, K. Kitamura, T. Eto, Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am. J. Hypertens. 18(3), 354\u2013357 (2005). doi: 10.1016\/j.amjhyper.2004.09.016","journal-title":"Am. J. Hypertens."},{"key":"316_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pa.29.040189.000323","volume":"29","author":"P Needleman","year":"1989","unstructured":"P. Needleman, E.H. Blaine, J.E. Greenwald, M.L. Michener, C.B. Saper, P.T. Stockmann, H.E. Tolunay, The biochemical pharmacology of atrial peptides. Annu. Rev. Pharmacol. Toxicol. 29, 23\u201354 (1989). doi: 10.1146\/annurev.pa.29.040189.000323","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"316_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00041552-199701000-00015","volume":"6","author":"K Kitamura","year":"1997","unstructured":"K. Kitamura, T. Eto, Adrenomedullin-physiological regulator of the cardiovascular system or biochemical curiosity? Curr. Opin. Nephrol. Hypertens. 6(1), 80\u201387 (1997)","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"55","key":"316_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.53738\/REVMED.2006.2.55.0582","volume":"2","author":"E Chollet-Dallon","year":"2006","unstructured":"E. Chollet-Dallon, C. Stoermann-Chopard, P.Y. Martin, Could cystatine C replace creatinine as a market of glomerular filtration rate? Revue medicale suisse 2(55), 582\u2013585 (2006)","journal-title":"Revue medicale suisse"},{"issue":"1\u20132","key":"316_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-8981(99)00128-X","volume":"287","author":"H Ohta","year":"1999","unstructured":"H. Ohta, T. Tsuji, S. Asai, S. Tanizaki, K. Sasakura, H. Teraoka, K. Kitamura, K. Kangawa, A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin. Chim. Acta 287(1\u20132), 131\u2013143 (1999)","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"316_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","author":"H Yasue","year":"1994","unstructured":"H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, K. Nakao, Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90(1), 195\u2013203 (1994)","journal-title":"Circulation"},{"issue":"1","key":"316_CR15","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1677\/ERC-10-0070","volume":"18","author":"DL Hay","year":"2011","unstructured":"D.L. Hay, C.S. Walker, D.R. Poyner, Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges. Endocr. Relat. Cancer 18(1), C1\u2013C14 (2011). doi: 10.1677\/erc-10-0244","journal-title":"Endocr. Relat. Cancer"},{"issue":"1\u20133","key":"316_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0167-0115(03)00023-5","volume":"112","author":"T Eto","year":"2003","unstructured":"T. Eto, J. Kato, K. Kitamura, Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul. Pept. 112(1\u20133), 61\u201369 (2003)","journal-title":"Regul. Pept."},{"issue":"3","key":"316_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1677\/joe.0.1560477","volume":"156","author":"S Kapas","year":"1998","unstructured":"S. Kapas, A. Martinez, F. Cuttitta, J.P. Hinson, Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J. Endocrinol. 156(3), 477\u2013484 (1998)","journal-title":"J. Endocrinol."},{"issue":"12","key":"316_CR18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0196-9781(99)00159-X","volume":"20","author":"G Mazzocchi","year":"1999","unstructured":"G. Mazzocchi, G. Albertin, P.G. Andreis, G. Neri, L.K. Malendowicz, H.C. Champion, M. Bahcelioglu, P.J. Kadowitz, G.G. Nussdorfer, Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland. Peptides 20(12), 1479\u20131487 (1999)","journal-title":"Peptides"},{"issue":"6","key":"316_CR19","first-page":"675","volume":"8","author":"M Forneris","year":"2001","unstructured":"M. Forneris, L. Gottardo, G. Albertin, L.K. Malendowicz, G.G. Nussdorfer, Expression and function of adrenomedullin and its receptors in Conn\u2019s adenoma cells. Int. J. Mol. Med. 8(6), 675\u2013679 (2001)","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"316_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/hr.2010.8","volume":"33","author":"T Kita","year":"2010","unstructured":"T. Kita, M. Tokashiki, K. Kitamura, Aldosterone antisecretagogue and antihypertensive actions of adrenomedullin in patients with primary aldosteronism. Hypertens. Res. 33(4), 374\u2013379 (2010). doi: 10.1038\/hr.2010.8","journal-title":"Hypertens. Res."},{"key":"316_CR21","doi-asserted-by":"crossref","unstructured":"D.G. Kong, H. Gao, Y.Q. Lu, X.W. Qi, L.L. Ma, X.Q. Kong, D.K. Yao, L.X. Wang, Anxiety disorders are associated with increased plasma adrenomedullin level and left ventricular hypertrophy in patients with hypertension,Clin. Exp. Hypertens. (New York, NY, 1993) (2013). doi: 10.3109\/10641963.2013.783049","DOI":"10.3109\/10641963.2013.783049"},{"issue":"8","key":"316_CR22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.jhh.1002033","volume":"20","author":"J Kato","year":"2006","unstructured":"J. Kato, K. Kitamura, T. Eto, Plasma adrenomedullin level and development of hypertension. J. Hum. Hypertens. 20(8), 566\u2013570 (2006). doi: 10.1038\/sj.jhh.1002033","journal-title":"J. Hum. Hypertens."},{"issue":"202","key":"316_CR23","first-page":"232","volume":"34","author":"A Grzywa-Celinska","year":"2013","unstructured":"A. Grzywa-Celinska, R. Celinski, K. Kwasniewska, M. Dyczko, A. Prystupa, J. Mosiewicz, The usefulness of natriuretic peptides measurements in the diagnostics of chosen cardiovascular diseases. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 34(202), 232\u2013234 (2013)","journal-title":"Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego"},{"issue":"7","key":"316_CR24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/10641963.2012.702831","volume":"34","author":"R Irzmanski","year":"2012","unstructured":"R. Irzmanski, L. Pawlicki, M. Charlusz, J. Kowalski, Concentration of natriuretic peptides in patients suffering from idiopathic arterial hypertension and left ventricular diastolic dysfunction confirmed by echocardiography. Clin. Exp. Hypertens. (New York, NY, 1993) 34(7), 530\u2013540 (2012). doi: 10.3109\/10641963.2012.702831","journal-title":"Clin. Exp. Hypertens. (New York, NY, 1993)"},{"issue":"3","key":"316_CR25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-013-0028-6","volume":"45","author":"F Pizzolo","year":"2014","unstructured":"F. Pizzolo, F. Zorzi, L. Chiecchi, L. Consoli, I. Aprili, P. Guarini, A. Castagna, G.L. Salvagno, C. Pavan, O. Olivieri, NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. Endocrine 45(3), 479\u2013486 (2014). doi: 10.1007\/s12020-013-0028-6","journal-title":"Endocrine"},{"issue":"1","key":"316_CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.HYP.27.1.102","volume":"27","author":"M Kohno","year":"1996","unstructured":"M. Kohno, T. Hanehira, H. Kano, T. Horio, K. Yokokawa, M. Ikeda, M. Minami, K. Yasunari, J. Yoshikawa, Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27(1), 102\u2013107 (1996)","journal-title":"Hypertension"},{"issue":"2","key":"316_CR27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, M. Mannelli, M.J. Matterello, D. Montemurro, G. Palumbo, D. Rizzoni, E. Rossi, A.C. Pessina, F. Mantero, Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48(2), 232\u2013238 (2006). doi: 10.1161\/01.HYP.0000230444.01215.6a","journal-title":"Hypertension"},{"issue":"1","key":"316_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/080370598437529","volume":"7","author":"C Letizia","year":"1998","unstructured":"C. Letizia, G. De Toma, S. Cerci, R. Massa, S. Coassin, S. Subioli, L. Scuro, A. De Ciocchis, Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure. Blood Press. 7(1), 19\u201323 (1998)","journal-title":"Blood Press."},{"issue":"2","key":"316_CR29","first-page":"126","volume":"3","author":"C Letizia","year":"2002","unstructured":"C. Letizia, S. Subioli, S. Cerci, C. Caliumi, C. Verrelli, E. Delfini, M. Celi, L. Scuro, E. D\u2019Erasmo, High plasma adrenomedullin concentrations in patients with high-renin essential hypertension. JRAAS 3(2), 126\u2013129 (2002). doi: 10.3317\/jraas.2002.014","journal-title":"JRAAS"},{"issue":"1","key":"316_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876526200801010001","volume":"1","author":"T Kita","year":"2008","unstructured":"T. Kita, M. Tokashiki, K. Kitamura, Long-term therapy with nifedipine-CR improves arterio-sclerosis related markers in patients with untreated essential hypertension. Open Hypertens. J. 1(1), 1\u20136 (2008)","journal-title":"Open Hypertens. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0316-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0316-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0316-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:23:50Z","timestamp":1716827030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0316-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0316-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}